Ignite Creation Date:
2024-05-06 @ 3:34 PM
Last Modification Date:
2024-10-26 @ 1:52 PM
Study NCT ID:
NCT04676360
Status:
RECRUITING
Last Update Posted:
2024-05-08
First Post:
2020-12-15
Brief Title:
Belantamab Mafodotin In Plasmablastic Lymphoma ALK Large B-Cell Lymphoma
Sponsor:
Organization:
Massachusetts General Hospital